![]() |
|
|
Vol. 300, Issue 3, 932-938, March 2002
Departments of Pharmacology (C.A.S., S.G.H.) and Chemistry
(J.B.J.), Emory University, Atlanta, Georgia
Opioid antagonists attenuate behavioral effects of amphetamine and
amphetamine-induced increases in extracellular dopamine levels in
nucleus accumbens and striatum of rats but do not alter those effects
of cocaine. This study was performed to determine 1) if the effect of
opioid antagonists on the dopamine response to amphetamine is mediated
in either the terminal or cell body region of the nigrostriatal and
mesolimbic pathways, and 2) if the enkephalinase inhibitor thiorphan,
which slows degradation of endogenous opioid peptides, increases the
dopamine response to amphetamine but not to cocaine. Microdialysis
probes were placed either into a dopaminergic terminal region or into
both a terminal and cell body region of rats. Naloxone methiodide (1.0 µM), a lipophobic opioid antagonist, was administered into either the terminal or cell body region by reverse dialysis, whereas extracellular dopamine was collected in the terminal region. Increases in
extracellular dopamine in nucleus accumbens and striatum caused by
amphetamine (0.1-6.4 mg/kg, s.c.) were reduced significantly
(28-39%) by naloxone methiodide administered into either substantia
nigra or ventral tegmentum but not into terminal regions. Thiorphan (10 µM) administered into substantia nigra increased significantly the
dopamine response to amphetamine in the ipsilateral striatum by as much
as 42% but did not affect the dopamine response to cocaine (3.0-56
mg/kg, i.p.). These results suggest that amphetamine promotes release of endogenous opioids, which, through actions in the ventral tegmentum and substantia nigra, contribute to amphetamine-induced increases in
extracellular dopamine in the nucleus accumbens and striatum.
This article has been cited by other articles:
![]() |
M. C. Borras, L. Becerra, A. Ploghaus, J. M. Gostic, A. DaSilva, R. G. Gonzalez, and D. Borsook FMRI Measurement of CNS Responses to Naloxone Infusion and Subsequent Mild Noxious Thermal Stimuli in Healthy Volunteers J Neurophysiol, June 1, 2004; 91(6): 2723 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Budygin, M. S. Brodie, T. D. Sotnikova, Y. Mateo, C. E. John, M. Cyr, R. R. Gainetdinov, and S. R. Jones Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine PNAS, May 18, 2004; 101(20): 7781 - 7786. [Abstract] [Full Text] [PDF] |
||||